Udo Wieshmann

The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Anthony G Marson, Girvan Burnside, Richard Appleton et al. · The Lancet · 2021 · 211 citations · Full text

Medicine, Neurology, Pharmacology +17

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Anthony G Marson, Girvan Burnside, Richard Appleton et al. · The Lancet · 2021 · 191 citations · Full text

Medicine, Neurology, Pharmacotherapy +15

Voxel-Based Morphometric Comparison of Hippocampal and Extrahippocampal Abnormalities in Patients with Left and Right Hippocampal Atrophy

Simon S. Keller, Clare E. Mackay, Thomas R. Barrick et al. · NeuroImage · 2002 · 185 citations

Life Sciences, Neurology, Neuroscience +8

Nonconvulsive status epilepticus: Epilepsy Research Foundation Workshop Reports

Matthew C. Walker, J. Helen Cross, Shelagh Smith et al. · Epileptic Disorders · 2005 · 181 citations

Medicine, Neurology, Clinical Neuroscience +9

Reduced anisotropy of water diffusion in structural cerebral abnormalities demonstrated with diffusion tensor imaging

Udo Wieshmann, Chris A. Clark, Mark R. Symms et al. · Magnetic Resonance Imaging · 1999 · 147 citations

Medicine, Neuroscience, Radiology +16